New imaging agent aims to spot Hard-to-Find cancers
Diagnosis
Terminated
This study was designed to test a new imaging agent called 111In-ABD147 that targets a protein (DLL3) found on many solid tumors, including prostate cancer and neuroendocrine tumors. The goal was to see if SPECT scans using this agent could better detect cancer that has spread. T…
Phase: EARLY_PHASE1 • Sponsor: Thomas Hope • Aim: Diagnosis
Last updated May 17, 2026 00:29 UTC